ACell Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
378
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$400M
ACell General Information
Description
Provider of extracellular matrix devices intended to leverage its platform technology to solve complex clinical problems in healing. The company manufactures products used in acute care settings as part of the treatment and management of wounds and reinforcement of soft tissue surgical defects.
Contact Information
Website
www.acell.comCorporate Office
- 6640 Eli Whitney Drive
- Columbia, MD 21046
- United States
Corporate Office
- 6640 Eli Whitney Drive
- Columbia, MD 21046
- United States
ACell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 20-Jan-2021 | $400M | Completed | Profitable | ||
| 5. IPO | 28-Jul-2020 | Cancelled | Profitable | |||
| 4. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series D) | 22-Apr-2011 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series C) | 24-Dec-2008 | $4.98M | $7.98M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 25-Feb-2002 | $3M | $3M | Completed | Product Development |
ACell Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 2,000,000 | $0.001000 | $3.27 | $3.27 | 1x | $1.09 | 17.61% | |
| Series A | 2,000,000 | $0.001000 | $1.5 | $1.5 | 1x | $1.5 | 5.87% |
ACell Comparisons
Industry
Financing
Details
ACell Competitors (17)
One of ACell’s 17 competitors is Isto Biologics, a Private Equity-Backed company based in Hopkinton, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Isto Biologics | Private Equity-Backed | Hopkinton, MA | ||||
| Nuo Therapeutics | Formerly VC-backed | Gaithersburg, MD | ||||
| TELA Bio | Formerly VC-backed | Malvern, PA | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Mimedx Group | Corporation | Marietta, GA |
ACell Patents
ACell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11826490-B1 | Extracellular matrix sheet devices with improved mechanical properties and method of making | Active | 29-Dec-2020 | ||
| WO-2022146730-A1 | Implantable pouch device and methods of making thereof | Inactive | 29-Dec-2020 | ||
| CA-3206678-A1 | Medical graft devices and methods of making thereof | Pending | 29-Dec-2020 | ||
| EP-4271426-A1 | Medical graft devices and methods of making thereof | Inactive | 29-Dec-2020 | ||
| US-20240316247-A1 | Medical graft devices and methods of making thereof | Inactive | 29-Dec-2020 | A61L27/3633 |
ACell Signals
ACell Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Haugo | Corporation | Minority |
ACell FAQs
-
When was ACell founded?
ACell was founded in 1999.
-
Where is ACell headquartered?
ACell is headquartered in Columbia, MD.
-
What is the size of ACell?
ACell has 378 total employees.
-
What industry is ACell in?
ACell’s primary industry is Surgical Devices.
-
Is ACell a private or public company?
ACell is a Private company.
-
What is the current valuation of ACell?
The current valuation of ACell is .
-
What is ACell’s current revenue?
The current revenue for ACell is .
-
How much funding has ACell raised over time?
ACell has raised $16.7M.
-
Who are ACell’s investors?
Haugo has invested in ACell.
-
Who are ACell’s competitors?
Isto Biologics, Nuo Therapeutics, TELA Bio, Medtronic, and Mimedx Group are some of the 17 competitors of ACell.
-
When was ACell acquired?
ACell was acquired on 20-Jan-2021.
-
Who acquired ACell?
ACell was acquired by Integra LifeSciences Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process